A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge

scientific article

A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00705-008-0250-3
P698PubMed publication ID19002647
P5875ResearchGate publication ID23467096

P50authorBenedito Antônio Lopes da FonsecaQ45879669
P2093author name stringDanielle Malta Lima
Sérgio Oliveira De Paula
Rafael Freitas de Oliveira França
Alessandra Cristina Gomes-Ruiz
P2860cites workDengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccineQ40699429
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectDengue virusQ476209
P1104number of pages9
P304page(s)2215-2223
P577publication date2008-11-12
P1433published inArchives of VirologyQ2860564
P1476titleA DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge
P478volume153

Reverse relations

cites work (P2860)
Q40342245A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection
Q33968024DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.
Q27304342Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
Q40342715Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection
Q40225317Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus
Q39118535Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts
Q39668466Genotype-specific neutralization and protection by antibodies against dengue virus type 3.
Q33961878Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines.
Q37904025Next generation dengue vaccines: a review of candidates in preclinical development
Q43296072Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.
Q35009119Progress towards a dengue vaccine
Q56960671Recent Developments in Recombinant Protein-Based Dengue Vaccines
Q38075857Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases
Q39187784Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design
Q39470840Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
Q37903445The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

Search more.